000			02589na a2200301 4500
999			_c6828 _d6828
003			PC6828
005			20210625062804.0
008			130622s2013 xxx||||| |||| 00| 0 eng d
040			_cH12O
041			_aeng
100			_aGutiérrez Martínez, Eduardo _9417 _eNefrología
100			_aGutiérrez Solís, Elena _92028 _eNefrología
100			_aHuerta Arroyo, Ana María _92031 _eNefrología
100			_aGutiérrez Millet, Víctor _9535 _d(1974-2013) _eNefrología
100			_aMorales Ruiz, Enrique _983 _eNefrología
100			_aPraga Terente, Manuel _91488 _eNefrología
245	0	0	_aRenoprotective effects of mineralocorticoid receptor blockers in patients with proteinuric kidney diseases. _h[artículo]
260			_bNephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, _c2013
300			_a28(2):405-12.
500			_aFormato Vancouver: Morales E, Millet VG, Rojas-Rivera J, Huerta A, Gutiérrez E, Gutiérrez-Solís E et al. Renoprotective effects of mineralocorticoid receptor blockers in patients with proteinuric kidney diseases. Nephrol Dial Transplant. 2013 Feb;28(2):405-12.
501			_aPMID: 23222416
504			_aContiene 26 referencias
520			_aBACKGROUND: Several studies have demonstrated a short-term antiproteinuric effect of mineralocorticoid receptor blockers (MRB) on proteinuric kidney diseases, but no information is available about the long-term persistence (>1 year) of such reduction in proteinuria and the long-term effects of MRB on renal function.
710			_986 _aServicio de Nefrología
710			_9625 _aInstituto de Investigación imas12
856			_uhttp://pc-h12o-es.m-hdoct.a17.csinet.es/pdf/pc/6/pc6828.pdf _ySolicitar documento
942			_n0 _2ddc _cART